Cargando…
Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine Release
Adjuvants enhance immunogenicity of vaccines through either targeted antigen delivery or stimulation of immune receptors. Three cationic nanoparticle formulations were evaluated for their potential as carriers for a DNA vaccine, and muramyl dipeptide (MDP) as immunostimulatory agent, to induce and i...
Autores principales: | Poecheim, Johanna, Heuking, Simon, Brunner, Livia, Barnier-Quer, Christophe, Collin, Nicolas, Borchard, Gerrit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304807/ https://www.ncbi.nlm.nih.gov/pubmed/28347123 http://dx.doi.org/10.3390/nano5042317 |
Ejemplares similares
-
Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune Responses
por: Poecheim, Johanna, et al.
Publicado: (2016) -
Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticles upon deposition at the human bronchial epithelium in vitro
por: Heuking, Simon, et al.
Publicado: (2013) -
Pulmonary Delivery of Plasmid DNA for Disease Prevention and Therapy
por: Heuking, Simon, et al.
Publicado: (2011) -
Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation
por: Younis, Sumera Y., et al.
Publicado: (2018) -
The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis
por: Bolourani, Siavash, et al.
Publicado: (2021)